Saudi Pharmaceutical
| Name | Saudi Pharmaceutical | |
| Sector | Manufacturing - Pharmaceuticals | |
| Trading | Tadawul | |
| RIC Code | 2070.SE | |
| Location | SAUDI ARABIA |
Profile and Background
Saudi Pharmaceutical Industries & Medical Appliances Corporation (Spimaco) was founded in 1986 with the objective of developing an indigenous pharmaceuticals industry. The private sector has an 80 per cent stake in the company.
The rest of the shares are owned by Amman-based Arab Company for Drug Industries & Medical Appliances. It manufactures generic medicines, and is seeking ISO 9001 certification for its factory in Buraidah, in central Saudi Arabia.
Recent developments include the establishment of the ARAC Healthcare Company, a joint venture with the Al-Khuraif Group. The new entity is to help market Spimaco products to retail customers. The deal will allow Al-Khuraif's network of 60 shops to sell Spimaco pharmaceuticals.
Spimaco has taken strategic stakes in local companies, including a 9 per cent share in Arabian Industrial Fibers Company (Ibn Rushd), the Yanbu-based polyester fiber company. Spimaco has a 25 per cent share in Asha'a, a limited liability X-ray film manufacturer, and a 51 per cent share in Enayah, a limited liability non-woven garment factory.
Spimaco is a minority shareholder in the Saudi Venture Capital Group. The company was adversely affected by slow and delayed payments for products supplied to the Health Ministry. All the amounts due to Spimaco are to be paid off in annual installments by the end of 2000.
The company reports that the Health Ministry is now paying in a timely way for orders placed since the end of 1994. In order to reduce Spimaco's exposure to government agencies, the company has worked hard to increase sales to the private sector and exports.
In 1996, these sales accounted for 44 per cent of total sales. In 1993, the figure was little more than 10 per cent. Nevertheless, the Health Ministry continues to be Spimaco's largest customer.
The rest of the shares are owned by Amman-based Arab Company for Drug Industries & Medical Appliances. It manufactures generic medicines, and is seeking ISO 9001 certification for its factory in Buraidah, in central Saudi Arabia.
Recent developments include the establishment of the ARAC Healthcare Company, a joint venture with the Al-Khuraif Group. The new entity is to help market Spimaco products to retail customers. The deal will allow Al-Khuraif's network of 60 shops to sell Spimaco pharmaceuticals.
Spimaco has taken strategic stakes in local companies, including a 9 per cent share in Arabian Industrial Fibers Company (Ibn Rushd), the Yanbu-based polyester fiber company. Spimaco has a 25 per cent share in Asha'a, a limited liability X-ray film manufacturer, and a 51 per cent share in Enayah, a limited liability non-woven garment factory.
Spimaco is a minority shareholder in the Saudi Venture Capital Group. The company was adversely affected by slow and delayed payments for products supplied to the Health Ministry. All the amounts due to Spimaco are to be paid off in annual installments by the end of 2000.
The company reports that the Health Ministry is now paying in a timely way for orders placed since the end of 1994. In order to reduce Spimaco's exposure to government agencies, the company has worked hard to increase sales to the private sector and exports.
In 1996, these sales accounted for 44 per cent of total sales. In 1993, the figure was little more than 10 per cent. Nevertheless, the Health Ministry continues to be Spimaco's largest customer.
Shareholding Groups
| Individuals | N/A |
| Institutions | 20% |
| Floating | N/A |
| Government | N/A |
Board Members (Listed in alphabetical order)
| Director | Abdullah A. Aba Al Khall |
| Director | Abdullah Bin Zamil Al Saleh Al Salim |
| Director | Abdulrahman Al Saleh Al Homaidan |
| Director | Fahed Ibrahim Suleiman Al Jarbou'a |
| Director | Mohammad Saad Al Nokhelan |
| Chairman | Saleh Abdulaziz Al Omeir |
| Director | Youssef Hassan Nasef |
Stock Performance
Market Information
| Stock | Saudi_Arabia Index | |
| Last Closing | SAR 51.5 | 3424.18 |
| YTD % | 3.587% | 0% |
| Weekly % | 3.587% | 5.55% |
| Year High | SAR 71 | 9083.39 |
| Year Low | SAR 44.25 | 3296.01 |
| 52 Week High | SAR 321.2 | 4532.55 |
| 52 Week Low | SAR 49 | 2983.01 |
| BETA | 1.1886 | |
| Outstanding Shares | 60,000,000 | |
| Market Cap | SAR 3,090,000,000 | |
| Market Cap in $ | USD $824,000,000 | |
| % of Saudi_Arabia Market | 0.25% | |
| % of Sector | 0.71% | |
| Rank by Cap | 40 |
Key Figures in '000 SAR
| 2004 | 2003 | 2002 | |
| Total Assets | 1,922,902 | 1,584,830 | 1,604,889 |
| Shareholder's Equity | 1,563,448 | 1,218,627 | 1,187,108 |
| NIAT | 65,485 | 40,105 | 80,500 |
| Dividends | 60,000 | 48,000 | 84,000 |
Financial Ratios
| 2004 | 2003 | 2002 | |
| Assets Growth | 21.33% | -1.25% | 0.60% |
| Earning Growth | 63.29% | -50.18% | 13.84% |
| ROaA | 3.73% | 2.52% | 5.03% |
| ROaE | 4.71% | 3.33% | 6.76% |
| No. Of Shares | 12,000,000 | 12,000,000 | 12,000,000 |
| EPS | 5.46 | 3.34 | 6.71 |
| EPS Growth | 63.29% | -50.18% | 13.84% |
| Payout Ratio | 91.623 | 119.686 | 104.348 |
Valuation Ratios
| Trailing | |
| PE | |
| PB | |
| DVPS | |
| Div Yield | |
| EV | |
| EV/Equity |

The information is this section is provided by SHUAA Capital PSC. The information contained in this section is not intended to be an offer, a recommendation, or a solicitation to buy or sell securities or investment products.
The information and opinions contained in this section have been compiled from, or arrived at in good faith, from sources believed to be reliable but no guarantee or warranty is made by SHUAA Capital or AME Info as to the accuracy or completeness of the information contained herein.
All opinions expressed herein are subject to change without notice.
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC.
© SHUAA Capital PSC. All rights reserved.

Web Feeds